CSIR Attested Ayurvedic Anti-Diabetic Drug BGR-34 Claimed To Be Best So Far

0
2056
Announcement Of Country’s First Ayurvedic Anti-Diabetic Drug BGR-34
Announcement Of Country’s First Ayurvedic Anti-Diabetic Drug BGR-34

Kolkata|

Diabetics is a bummer- it has no cure – it can only be regulated and even then the usual allopathic drugs are partially effective. Years of research has led CSIR to formulate a regulator, BGR-34, an Ayurvedic pill, country’s first and touted to be the best thus far to combat type 2 Diabetes mellitus. They have settled on AIMIL Pharmaceuticals to make it available to the masses.

Dr. A.K.S. Rawat, Sr. Principal Scientist, CSIR-NBRI said at a recent launch, “BGR-34 works by controlling blood sugar and limiting the harmful effects of other drugs while modern diabetic drugs are known for side-effects and toxicity.”

What’s in it? This BGR – Blood Glucose Regulator comprises herbs – Daruharidra (Berberis aristata), Giloy (Tinospora cordifolia), Vijaysar (Pterocarpus marsupium), Gudmar (Gymnema sylvestre), Majeeth (Rubia cordifoila) and Methika (Trigonella foenum-graecum) which collectively releases 34 active phyto-constituents in the recipient body, hence the name.

Berberine in Daruharidra contains DPP4 inhibitors and Columbamine and Jatrorrhizine in the same are insulin secretagogues. Giloy has an insulin mimicking and releasing effect, Vijaysar is anti-hyperglycemic and converts pro-insulin to insulin, Gudmar helps regenerate pancreatic cells and delays glucose absorption in blood, Majeeth is a strong anti-oxidant and Methika slows down metabolism.

These tablets not only control the physical effects of diabetes but also fortify internal organ-functions to lend a holistic support by making the body stronger to fight the disease.

Developed jointly by researchers of National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plants (CIMAP), the research units of CSIR, Govt. of India situated at Lucknow, they had decided on these 6 herbs amongst an in-depth study of over 500 renowned ancient herbs and on particular composition only after thorough tests to produce optimal results.

Dr Ch V Rao, Principal Scientist CSIR-NBRI, attested, “The product passed several battery of tests and showed hypoglycemic activity in experimental subjects.” Overall the tablets have recorded a 67-70% success rate over a batch of 100 individuals. Pre-clinical studies showed significant reduction in high blood sugar level in diabetics, the activity being comparable with the reference standard anti-diabetic allopathic drug. Besides, the drug was found to improve LFTs, KFT’s and lipid profile significantly. It also provided the much needed pronounced antioxidant protective activity. No untoward side-effects were recorded. In fact 10x dosage administer to mice didn’t throw up ant worry graph.

One will need two doses of 2 tablets per day half-hour prior to main meals or as directed by physicians. To make it affordable each tablet has been a priced at only Rs 5/- and a phial consists of 100 tablets.

AIMIL Pharmaceuticals, no stranger to working with government bodies, having collaborated with DRDO (Defence Research and Development Organization) on Lukoskin – an ointment for leucoderma are the manufacturing and distributing partners. They have been bestowed with 3 national awards from Govt. of India for manufacturing herbal medicines of outstanding quality and also for research and development activities.

K. Sharma, Managing director of AIMIL Pharmaceuticals, said “We are happy to be partner with institutes of such repute for passing on its benefits to the people.”

If the medicine works no less than 6 Crore plus sufferers will benefit.